Stage IA ovarian cancers: Comparison of sonographic findings and histopathologic types between patients with normal and elevated serum cancer antigen 125 levels

Journal of Ultrasound in Medicine

Volumn 30, Issue 7, 2011, Pages 943-952

  Hirai, Makiko ^a   Hirai, Yasuo ^a   Tsuchida, Tomohiro ^a   Takada, Toshio ^a   Iwase, Haruko ^a   Utsugi, Kuniko ^a   Sugiyama, Yuko ^a   Takeshima, Nobuhiro ^a   Furuta, Reiko ^a   Takizawa, Ken ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Cancer antigen 125; Sonography; Stage IA ovarian cancers

Indexed keywords

ANTIGENS; BODY FLUIDS; DIAGNOSIS; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

CANCER ANTIGEN 125; DIFFERENT DISTRIBUTIONS; ENDOMETRIOID ADENOCARCINOMA; OVARIAN CANCERS; SOLID COMPONENTS; SOLID TUMORS; SONOGRAPHIC FINDINGS; STATISTICALLY SIGNIFICANT DIFFERENCE;

DISEASES;

CA 125 ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ECHOGRAPHY; FEMALE; HUMAN; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959611657     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2011.30.7.943     Document Type: Article

References (18)

1. Tailor A, Bourne TH, Campbell S, Okokon E, Dew T, Collins WP. Results from an ultrasound-based familial ovarian cancer screening clinic: 10- year observational study. Ultrasound Obstet Gynecol 2003; 21:378-385. (Pubitemid 36555118)
2. Bourne TH, Campbell S, Reynolds KM, et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour flow imaging. BMJ 1993; 306:1025-1029. (Pubitemid 23105959)
3. van Nagell JR Jr, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened. Cancer 2007; 109:1887-1896. (Pubitemid 46668555)
4. Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005; 193:1630-1639. (Pubitemid 41540458)
5. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999; 353:1207-1210. (Pubitemid 29168457)
6. Menon U, Gentry-Maharaj A, Hallet R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009; 10:327-340.
7. Bast RC Jr, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309:883-887. (Pubitemid 13014028)
8. Woolas RP, Jacobs FJ, Yu YH, et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst 1993; 85:1748-1751. (Pubitemid 23320845)
9. Gotlieb WH, Soriano D, Achiron R, et al. CA 125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol 2000; 183:541-546.
10. Engelen MJ, de Bruijn HW, Hollema H, et al. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 2000; 78:16-20. (Pubitemid 30439472)
11. Timmerman D, Valentine L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 2000; 16:500-505. (Pubitemid 32158133)
12. DiSaia PJ. The adnexal mass and early ovarian cancer. In: DiSaia PJ, Creasman WT (eds). Clinical Gynecologic Oncology. 7th ed. St Louis, MO: CV Mosby Co; 2007:283-312.
13. Kolwijck E, Thomas CM, Bulten J, Massuger LF. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol Cancer 2009; 19:1335-1338.
14. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008; 109:370-376.
15. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ (ed). Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY. Springer; 2002:791-904.
16. Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006; 94:1369-1374. (Pubitemid 43772268)
17. Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 2008; 313:681-690.
18. Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR Jr. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol 2003; 102:594-599. (Pubitemid 37311227)